These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33556539)

  • 21. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
    Trojan E; Tylek K; Schröder N; Kahl I; Brandenburg LO; Mastromarino M; Leopoldo M; Basta-Kaim A; Lacivita E
    Mol Neurobiol; 2021 Dec; 58(12):6203-6221. PubMed ID: 34468933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
    Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
    Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice.
    Woodhouse A; Fernandez-Martos CM; Atkinson RAK; Hanson KA; Collins JM; O'Mara AR; Terblanche N; Skinner MW; Vickers JC; King AE
    BMC Anesthesiol; 2018 Apr; 18(1):47. PubMed ID: 29699479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice.
    Huang H; Wang L; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu116. PubMed ID: 25568286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis.
    Wang J; Liu B; Xu Y; Luan H; Wang C; Yang M; Zhao R; Song M; Liu J; Sun L; You J; Wang W; Sun F; Yan H
    Exp Neurol; 2022 Jan; 347():113870. PubMed ID: 34563511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.
    Casali BT; Reed-Geaghan EG; Landreth GE
    J Neuroinflammation; 2018 Feb; 15(1):43. PubMed ID: 29448961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Intermittent Hypoxia Induces Robust Astrogliosis in an Alzheimer's Disease-Relevant Mouse Model.
    Macheda T; Roberts K; Lyons DN; Higgins E; Ritter KJ; Lin AL; Alilain WJ; Bachstetter AD
    Neuroscience; 2019 Feb; 398():55-63. PubMed ID: 30529693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
    Jiang H; Niu F; Zheng Y; Xu Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease.
    Chen Y; Fang L; Chen S; Zhou H; Fan Y; Lin L; Li J; Xu J; Chen Y; Ma Y; Chen Y
    Biomed Res Int; 2020; 2020():8456596. PubMed ID: 32596386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
    Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.